Abstract
Background
Hand-expression, collection, and storage of breast milk during pregnancy (i.e., antenatal milk expression or AME) is a safe, potentially effective practice to reduce early, undesired formula supplementation among women with diabetes. The feasibility and potential benefits of AME in the United States (U.S.) and among non-diabetic birthing people is unknown.
Methods
The purpose of this study was to examine the feasibility of a structured AME intervention and its relationship to lactation outcomes among nulliparous birthing people in the United States. We recruited a convenience sample of 45 low-risk, nulliparous individuals at 34–366/7 weeks of gestation from a hospital-based midwife practice. Participants were randomized to AME or a control group receiving breastfeeding handouts. Interventions were delivered at weekly visits at 37–40 weeks of pregnancy. The AME intervention involved technique demonstration and feedback from a lactation consultant and daily independent practice. Lactation outcomes were assessed during the postpartum hospitalization, 1–2 weeks postpartum, and 3–4 months postpartum.
Results
Of 22 participants assigned to AME, 18 received an AME education study visit. Participants reported practicing AME on 60% or more of days prior to their infant’s birth. Most were able to express milk antenatally (15/18), more than half collected and froze antenatal milk (11/18), and 39% (7/18) supplemented their infants with antenatal milk after birth. No major problems were reported with AME. Perinatal and lactation outcomes, including infant gestational age at birth, neonatal intensive care unit admissions, and any or exclusive breastfeeding, appeared to be comparable between AME and control groups. There were trends toward higher breastfeeding self-efficacy and lower perceptions of insufficient milk postpartum among AME participants compared to control group participants, though AME participants exhibited higher breastfeeding self-efficacy and more favorable attitudes toward breastfeeding at baseline.
Conclusions
In a group of nulliparous birthing people in the U.S., AME education and independent practice beginning at 37 weeks of pregnancy was feasible and safe. In some cases, AME provided a back-up supply of breast milk when supplementation of direct breastfeeding was indicated or desired. The relationship between AME and lactation outcomes requires further study within a powered sample and other populations.
Trial Registration:
This trial was retrospectively registered at ClinicalTrials.gov on May 11, 2021 under the following registration ID: NCT04929301. https://clinicaltrials.gov/ct2/show/NCT04929301